Young Innovations acquires Germiphene Corporation

Young Innovations, a leading global supplier of dental products, today announced the acquisition of Germiphene Corporation (“Germiphene”). Based in Brantford, ON, Canada, Germiphene is a leading manufacturer and supplier of infection control, materials and other products for professional dental use.

“Since 1952, Germiphene has built its reputation on developing and manufacturing high-quality products to improve the safety and efficacy of dental procedures,” says Dave Sproat, CEO of Young Innovations. “We are excited to support the continued growth of Germiphene’s employees, business partners and brands as a part of our broader global portfolio.”

Read more: Young Innovations diversifies portfolio with Crystal Tips buy

“Our acquisition of Germiphene reflects our continued commitment to invest in businesses that share our values and complement our overall strategy in core categories,” says Andrew Jones, vice president of corporate development at Young Innovations. “We also take pride our ability to partner with business owners at an unparalleled pace in today’s evolving dental market.”

“I am exceptionally proud of the company we’ve built over nearly 70 years with our valued employees and business partners,” says Leslie Drake, CEO and owner of Germiphene. “I’m excited to be partnered with Young to continue growing Germiphene into the future.”

Leslie Drake will continue to provide leadership and support at Germiphene. Germiphene products will continue to be proudly made in Canada at its Brantford facility. There are no changes to ordering and service procedures for customers or vendors.

Young Innovations, Inc. is a portfolio company of The Jordan Company.